Unknown

Dataset Information

0

Designing a chemical inhibitor for the AAA protein spastin using active site mutations.


ABSTRACT: Spastin is a microtubule-severing AAA (ATPases associated with diverse cellular activities) protein needed for cell division and intracellular vesicle transport. Currently, we lack chemical inhibitors to probe spastin function in such dynamic cellular processes. To design a chemical inhibitor of spastin, we tested selected heterocyclic scaffolds against wild-type protein and constructs with engineered mutations in the nucleotide-binding site that do not substantially disrupt ATPase activity. These data, along with computational docking, guided improvements in compound potency and selectivity and led to spastazoline, a pyrazolyl-pyrrolopyrimidine-based cell-permeable probe for spastin. These studies also identified spastazoline-resistance-conferring point mutations in spastin. Spastazoline, along with the matched inhibitor-sensitive and inhibitor-resistant cell lines we generated, were used in parallel experiments to dissect spastin-specific phenotypes in dividing cells. Together, our findings suggest how chemical probes for AAA proteins, along with inhibitor resistance-conferring mutations, can be designed and used to dissect dynamic cellular processes.

SUBMITTER: Cupido T 

PROVIDER: S-EPMC6558985 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Designing a chemical inhibitor for the AAA protein spastin using active site mutations.

Cupido Tommaso T   Pisa Rudolf R   Kelley Megan E ME   Kapoor Tarun M TM  

Nature chemical biology 20190218 5


Spastin is a microtubule-severing AAA (ATPases associated with diverse cellular activities) protein needed for cell division and intracellular vesicle transport. Currently, we lack chemical inhibitors to probe spastin function in such dynamic cellular processes. To design a chemical inhibitor of spastin, we tested selected heterocyclic scaffolds against wild-type protein and constructs with engineered mutations in the nucleotide-binding site that do not substantially disrupt ATPase activity. The  ...[more]

Similar Datasets

| S-EPMC6637947 | biostudies-literature
| S-EPMC1950444 | biostudies-literature
| S-EPMC3411929 | biostudies-literature
| S-EPMC3406712 | biostudies-literature
| S-EPMC5065787 | biostudies-literature
| S-EPMC208762 | biostudies-literature
| S-EPMC305661 | biostudies-literature
| S-EPMC2859577 | biostudies-literature
| S-EPMC3158820 | biostudies-literature